# Prognostic Impact of Adjuvant Therapy in Primary Hepatic Sarcomatoid Carcinoma

> **NCT06950814** · — · RECRUITING · sponsor: **West China Hospital** · enrollment: 50 (estimated)

## Conditions studied

- Sarcomatoid Carcinoma
- Liver Cancer
- Adjuvant Therapy

## Interventions

- **PROCEDURE:** postoperative adjuvant therapy

## Key facts

- **NCT ID:** NCT06950814
- **Lead sponsor:** West China Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2025-04-05
- **Primary completion:** 2025-05-03
- **Final completion:** 2025-05-05
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2025-04-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06950814

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06950814, "Prognostic Impact of Adjuvant Therapy in Primary Hepatic Sarcomatoid Carcinoma". Retrieved via AI Analytics 2026-06-10 from https://api.ai-analytics.org/clinical/NCT06950814. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*